Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks
- 1 June 1985
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 21 (6) , 880-883
- https://doi.org/10.1128/jcm.21.6.880-883.1985
Abstract
Evaluations of 5-.mu.g ciprofloxacin disk diffusion susceptibility tests were performed independently by 7 different investigators. The results of the separate tests were combined to increase the number of resistant strains in the challenge set of microorganisms. Based on data with 2652 isolates, the following interpretive breakpoints are tentatively proposed for use in ongoing clinical trials of ciprofloxacin: .ltoreq. 15 mm, resistant (MIC [minimum inhibitory concentration] > 2.0 .mu.g/ml); 16-20 mm, intermediate (1.0 < MIC .ltoreq. 2.0 .mu.g/ml); and .gtoreq. 21 mm, susceptible (MIC .ltoreq. 1.0 .mu.g/ml). Disk tests with Streptococcus spp. and with Pseudomonas maltophilia were not reliable; other microorganisms were accurately categorized by the disk diffusion test.This publication has 19 references indexed in Scilit:
- Diffusion of ciprofloxacin into prostatic fluidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Dose- and sex-independent disposition of ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Pharmacokinetics of intravenously administered ciprofloxacinAntimicrobial Agents and Chemotherapy, 1984
- Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acidAntimicrobial Agents and Chemotherapy, 1984
- In-vitro studies with ciprofloxacin, a new 4-quinolone compoundJournal of Antimicrobial Chemotherapy, 1984
- The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acidJournal of Antimicrobial Chemotherapy, 1984
- Pharmacokinetics and tissue penetration of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1983
- Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acidAntimicrobial Agents and Chemotherapy, 1983
- In vitro activity of ciprofloxacin, norfloxacin and nalidixic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- Susceptibility Tests of Anaerobic Bacteria: Statistical and Clinical ConsiderationsThe Journal of Infectious Diseases, 1974